December 1, 2014

homepage

January 6, 2021

Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases

Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases Paris and Waltham, Mass.; Jan. 6, 2021 (Business Wire) – Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced today a partnership to identify and develop novel small molecules for the treatment of neurological disorders. Under the terms of […]

Continue Reading
Continue Reading
October 1, 2020

Proteros Biostructures and X-Chem to offer Comprehensive Joint Target-to-Lead Drug Discovery Services

Munich, Germany and Waltham, Mass –October 1, 2020 – Proteros Biostructures GmbH (Proteros) and X-Chem, Inc. (X-Chem) announced today the launch of an alliance with the goal of offering Hit-Identification and Target-to-Lead drug discovery services based on their complementary technology platforms. The alliance combines Proteros’ strengths in protein sciences, structural biology (crystallography and CryoEM), and […]

Continue Reading